POINT Biopharma Global (PNT) Short Interest Ratio & Short Volume

Short interest is the volume of POINT Biopharma Global shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 3,000,000 shares of PNT short. 3.42% of POINT Biopharma Global's shares are currently sold short. Learn More on POINT Biopharma Global's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PNT shares currently have a short interest ratio of 1.0. Learn More on POINT Biopharma Global's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of POINT Biopharma Global: Perceptive Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.42% of POINT Biopharma Global's floating shares are currently sold short.

POINT Biopharma Global saw a increase in short interest in December. As of December 15th, there was short interest totaling 3,000,000 shares, an increase of 13.6% from the previous total of 2,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

POINT Biopharma Global currently has issued a total of 106,570,000 shares. Some of POINT Biopharma Global's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. POINT Biopharma Global currently has a public float of 87,710,000 shares.

3.42% of POINT Biopharma Global's shares are currently sold short. Here is how the short interest of companies compare to POINT Biopharma Global: Verona Pharma plc (8.12%), Gyre Therapeutics, Inc. (0.87%), ANI Pharmaceuticals, Inc. (0.93%), Day One Biopharmaceuticals, Inc. (15.24%), Morphic Holding, Inc. (11.79%), Ligand Pharmaceuticals Incorporated (4.05%), Pacira BioSciences, Inc. (8.04%), Kura Oncology, Inc. (16.38%), Ironwood Pharmaceuticals, Inc. (14.48%), Zai Lab Limited (3.90%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($4.67 billion), General Motors ($4.33 billion), T-Mobile US, Inc. ($4.30 billion), Charter Communications, Inc. ($3.12 billion), Coinbase Global, Inc. ($3.12 billion), Occidental Petroleum Co. ($2.94 billion), Tractor Supply ($2.71 billion), Rivian Automotive, Inc. ($2.32 billion), United Rentals, Inc. ($2.22 billion), and Royal Caribbean Cruises Ltd. ($2.04 billion). View all of the most shorted stocks.

Short selling PNT is an investing strategy that aims to generate trading profit from POINT Biopharma Global as its price is falling. PNT shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for POINT Biopharma Global occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PNT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PNT, twice per month. The most recent reporting period available is December, 15 2023.